Skip to main content

Proceeding contribution from Baroness Thornton (Labour) in the House of Lords on Tuesday, 21 October 2008. It occurred during Debates on delegated legislation on Health Service Branded Medicines (Control of Prices and Supply of Information) Regulations 2008.


Health Service Branded Medicines (Control of Prices and Supply of Information) Regulations 2008

My Lords, the noble Earl and I had an exchange of views on this. I have two observations. First, this scheme is intended to run unamended for a mere four months, so three monthly reporting in a four-month scheme seems less than sensible. That is why there is monthly reporting. Secondly, as the negotiations progress, and given that the Government’s aim is to have something which is broadly similar to what has gone before, while I cannot say that quarterly reporting will be reinstated I can say that the matter is being negotiated.


Secondary information

Type
Proceeding contribution
Reference
704 c1117 
Session
2007-08
Chamber / Committee
House of Lords chamber
Subjects
Drugs NHS Prices Price caps Prescriptions Regulation Pharmaceutical price regulation scheme Association of the British Pharmaceutical Industry
Legislation
Health Service Branded Medicines (Control of Prices and Supply of Information) Regulations 2008
Link
View this Proceeding contribution on www.publications.parliament.uk